Inflammatory bowel diseases and primary sclerosing cholangitis: hepatic and pancreatic side effects due to azathioprine.

Pallavicino, F; Pellicano, R; Reggiani, S; Simondi, D; Sguazzini, C; Bonagura, A G; Cisarò, F; Rizzetto, M; Astegiano, M

Pallavicino, F; Pellicano, R; Reggiani, S; Simondi, D; Sguazzini, C; Bonagura, A G; Cisarò, F; Rizzetto, M; Astegiano, M.

Affiliation

Pallavicino F; Department of Gastroenterology and Hepatology, Molinette Hospital, Torino, Italy.

Eur Rev Med Pharmacol Sci ; 17(1): 84-7, 2013 Jan.

Article in En | MEDLINE | ID: mdl-23329527

Subject(s)

Azathioprine/adverse effects; Cholangitis, Sclerosing/complications; Inflammatory Bowel Diseases/drug therapy; Liver/drug effects; Pancreas/drug effects; Adolescent; Adult; Child; Female; Humans; Liver Transplantation; Male; Retrospective Studies

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Pancreas / Azathioprine / Cholangitis, Sclerosing / Inflammatory Bowel Diseases / Liver Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Female / Humans / Male Language: En Year: 2013 Type: Article

Search on Google

XML

PubMed Links